Account for Clinical Heterogeneity in Assessment of Catheter-based Renal Denervation among Resistant

来源 :中华医学杂志(英文版) | 被引量 : 0次 | 上传用户:xiwang452
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:Catheter-based renal denervation (RDN) is a novel treatment for resistant hypertension (RH).A recent meta-analysis reported that RDN did not significantly reduce blood pressure (BP) based on the pooled effects with mild to severe heterogeneity.The aim of the present study was to identify and reduce clinical sources of heterogeneity and reassess the safety and efficacy of RDN within the identified homogeneous subpopulations.Methods:This was a meta-analysis of 9 randomized clinical trials (RCTs) among patients with RH up to June 2016.Sensitivity analyses and subgroup analyses were extensively conducted by baseline systolic blood pressure (SBP) level,antihypertensive medication change rates,and coronary heart disease (CHD).Results:In all patients with RH,no statistical differences were found in mortality,severe cardiovascular events rate,and changes in 24-h SBP and office SBP at 6 and 12 months.However,subgroup analyses showed significant differences between the RDN and control groups.In the subpopulations with baseline 24-h SBP >155 mmHg (1 mmHg =0.133 kPa) and the infrequently changed medication,the use of RDN resulted in a significant reduction in 24-h SBP level at 6 months (P =0.100 and P =0.009,respectively).Subgrouping RCTs with a higher prevalent CHD in control showed that the control treatment was significantly better than RDN in office SBP reduction at 6 months (P < 0.001).Conclusions:In all patients with RH,the catheter-based RDN is not more effective in lowering ambulatory or office BP than an optimized antihypertensive drug treatment at 6 and 12 months.However,among RH patients with higher baseline SBP,RDN might be more effective in reducing SBP.
其他文献
Background:Giant cell tumors (GCTs) are benign,locally aggressive tumors.We examined the rate of local recurrence of spinal GCTs and sought to identify recurren
期刊
Background:Chronic intermittent hypoxia is the most remarkable feature of obstructive sleep apnea/hypopnea syndrome and it can induce the change of hypoxia-indu
目的 分析和总结脾边缘区B细胞淋巴瘤(SMZL)的临床病理特点、探讨其诊断与鉴别诊断要点.方法 对8例原发性SMZL的临床资料行回顾性分析总结、组织切片的形态观察和免疫组织化学EliVision法染色分析,并对部分病例行基因重排克隆性检测,获得4例随访资料.结果 8例SMZL的中位年龄为61.5岁(36~75岁),男女比例为1.7:1.患者均因脾大就诊,5例伴血象异常,白细胞和血小板均低于正常,其
结合实际工程经验,利用杆塔场强图,针对220 kV输电线路中导线在杆塔的布置情况和换位方式,对ADSS光缆在几种典型杆塔和导线排列形式下的悬挂点进行了选择探讨.
新生儿听力筛查是早期发现听力损失的一种有效手段,但不能发现迟发性听力损失。探讨儿童迟发性听力损失的病因,可为早期检测和发现迟发性听力损失提供临床依据。SLC26A4、线粒体、GJB2等基因突变、前庭导水管扩大、先天性巨细胞病毒感染、体外膜肺氧合及听神经病等是报道较多的迟发性听力损失致病因素。本文拟从遗传因素、内耳畸形、围产期因素、听神经病及原因未明确5个方面,对近年来报道的儿童迟发性听力损失相关因
小儿急性胰腺炎(CAP)是小儿常见急腹症之一。据文献报道,近年来发病率有明显上升。绝大多数小儿急性胰腺炎为水肿型,预后良好。而坏死性胰腺炎死亡率高达30%~40%。故早期诊断